Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 2 days ago • ZTS
Zoetis Inc. (ZTS) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Seeking Alpha • 6 days ago • ZTS
Zoetis: The King Of Animal Health On Sale
Zacks Investment Research • 6 days ago • ZTS
Zoetis (ZTS) Loses 8.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks Investment Research • 7 days ago • ZTS
USNA or ZTS: Which Is the Better Value Stock Right Now?
Business Wire • 7 days ago • ZTS
Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.